We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SHOP:NASDAQShopify Inc. Analysis

Data as of 2026-03-14 - not real-time

$122.96

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Shopify (SHOP) is trading at $122.96, well below its 20‑day (≈$123.8), 50‑day (≈$134.9) and 200‑day (≈$140.2) moving averages, signaling a bearish price trend despite a neutral RSI of 45.5 and a bullish MACD histogram. Volume is declining and the 30‑day volatility sits near 75%, while a beta above 2 underscores heightened market sensitivity. Fundamentally, the company posted 30.6% YoY revenue growth to $11.56 B, with solid gross (48%) and operating (20%) margins, but trades at a trailing P/E of 132 versus an industry average of 33 and a DCF‑derived fair value of only $41, indicating pronounced overvaluation.
The recent Q4 2025 earnings missed EPS expectations (reported $0.48 vs $0.51 consensus) and the stock dipped, yet analysts remain optimistic with a median 12‑month target of $160 and a “Buy” consensus. The lack of dividend, high leverage (debt‑to‑equity ≈ 1.4) and a “Greed” sentiment index (72.9) suggest speculative upside, but the valuation gap and technical weakness warrant caution. Investors should weigh the strong growth narrative against the risk of a valuation correction.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below key moving averages and decreasing volume
  • Q4 EPS miss and short‑term sentiment shift
  • High valuation relative to DCF fair value

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained 30% revenue growth and strong operating margins
  • Positive MACD histogram indicating potential reversal
  • Analyst consensus buy with median target of $160

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Robust platform expansion opportunities and AI‑driven commerce
  • Elevated beta and volatility suggesting price swings
  • Valuation gap may compress, but growth fundamentals remain solid

Key Metrics & Analysis

Financial Health

Revenue Growth30.60%
Profit Margin10.65%
P/E Ratio132.2
ROE9.84%
ROA8.15%
Debt/Equity1.40
P/B Ratio11.9
Op. Cash Flow$2.0B
Free Cash Flow$1.3B
Industry P/E33.7

Technical Analysis

TrendBearish
RSI45.6
Support$107.43
Resistance$135.96
MA 20$123.82
MA 50$134.91
MA 200$140.23
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value$41.08
Target Price$160.04
Upside/Downside30.16%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.19
Volatility74.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.